New diabetes clinical trial: A Research Study to See How Well CagriSema Compared to Semaglutide, Cagrilintide and Placebo Lowers Blood Sugar and Body Weight in People With Type 2 Diabetes Treated With Metformin With or Without an SGLT2 Inhibitor

Published on: October 03, 2023 at 11:00PM
Conditions: Type 2 Diabetes Mellitus
Interventions: Drug: Cagrilintide; Drug: Semaglutide; Drug: Placebo cagrilintide; Drug: Placebo semaglutide
Sponsors: Novo Nordisk A/S
Not yet recruiting
https://ift.tt/7dDSlRN